Page last updated: 2024-10-25

deferiprone and Allergic Encephalomyelitis

deferiprone has been researched along with Allergic Encephalomyelitis in 2 studies

Deferiprone: A pyridone derivative and iron chelator that is used in the treatment of IRON OVERLOAD in patients with THALASSEMIA.
deferiprone : A member of the class of 4-pyridones that is pyridin-4(1H)-one substituted at positions 1 and 2 by methyl groups and at position 3 by a hydroxy group. A lipid-soluble iron-chelator used for treatment of thalassaemia.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Khan, RS1
Baumann, B1
Dine, K1
Song, Y1
Dunaief, JL1
Kim, SF1
Shindler, KS1
Mitchell, KM1
Dotson, AL1
Cool, KM1
Chakrabarty, A1
Benedict, SH1
LeVine, SM1

Other Studies

2 other studies available for deferiprone and Allergic Encephalomyelitis

ArticleYear
Dexras1 Deletion and Iron Chelation Promote Neuroprotection in Experimental Optic Neuritis.
    Scientific reports, 2019, 08-12, Volume: 9, Issue:1

    Topics: Animals; Chelating Agents; Deferiprone; Encephalomyelitis, Autoimmune, Experimental; Female; Humans;

2019
Deferiprone, an orally deliverable iron chelator, ameliorates experimental autoimmune encephalomyelitis.
    Multiple sclerosis (Houndmills, Basingstoke, England), 2007, Volume: 13, Issue:9

    Topics: Administration, Oral; Animals; Cell Division; Deferiprone; Encephalomyelitis, Autoimmune, Experiment

2007